Area of research
Radiology, Nuclear Medicine and Imaging · Hepatology
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Hepatocellular Carcinoma Treatment and Prognosis, and MRI in cancer diagnosis.
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification
Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
Trans-arterial embolization for treatment of acute lower gastrointestinal bleeding—a multicenter analysis
AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter study
Fibroblast Activation Protein–Directed Imaging Outperforms<sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the<sup>68</sup>Ga-FAPI PET Observational Trial
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
Automated imaging-based abdominal organ segmentation and quality control in 20,000 participants of the UK Biobank and German National Cohort Studies
Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by<sup>90</sup>Y Radioembolization: A Multicenter Retrospective Study
Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases
<sup>90</sup>Y radioembolization in the treatment of neuroendocrine neoplasms: Results of an international multicenter retrospective study.
Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion
Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?